Navigation Links
Results of the NEXT clinical trial Reported at TCT 2011
Date:11/11/2011

SAN FRANCISCO, CA NOVEMBER 11, 2011 Researchers have found that polymer-free amphilimus-eluting stents in de novo coronary artery lesions showed a significantly lower in-stent late loss at six months compared to paclitaxel-eluting stents with permanent polymers.

Results of the NEXT trial were presented today at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. NEXT is a prospective, randomized trial comparing a polymer-free amphilimus-eluting stent to a paclitaxel-eluting stent.

The risk/benefit balance of coronary drug-eluting stents is still suboptimal, and the safety of coating polymers, which hold and release the drug over time, remains uncertain. Researchers sought to demonstrate the non-inferiority of polymer-free amphilimus-eluting stents versus permanent-polymer paclitaxel-eluting stents in de novo native coronary artery lesions. The primary endpoint was six-month angiographic in-stent late loss within a non-inferiority scope. Late loss is the difference between the diameter of a stented segment post-procedure compared with the follow-up angiogram.

A total of 323 patients were enrolled, with 162 randomized to amphilimus-eluting stents and 161 to paclitaxel-eluting stents. In-stent late loss was significantly lower with amphilimus-eluting stents (0.140.36 mm vs. 0.340.40 mm, P<0.0001 for non-inferiority, P<0.0001 for superiority). Clinical endpoints (cardiac death, myocardial infarction, target lesion revascularization or stent thrombosis) up to 12 months did not differ significantly.

"These results are encouraging evidence that support the use of polymer-free stents, but further studies are warranted to prove that this potent polymer-free stent can improve the risk-benefit balance of coronary drug-eluting stents," said Didier Carri, MD, PhD, the principal investigator of the trial. Dr. Carri is Professor of Medicine, Cardiology at the University of Paul Sabatier and the Head of Hemodynamics and Angioplasty Section at Rangueil Hospital in Toulouse, France.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Results of the PEPCAD-DES trial reported at TCT 2011
2. Results of the STACCATO Trial reported at TCT 2011
3. Results of the DEB-AMI Trial reported at TCT 2011
4. Results of the RIFLE STEACS clinical trial reported at TCT 2011
5. Results of the PARTNER Trial Cohort B 2-year follow up presented at TCT 2011
6. Results of the PARTNER Trial Cohort A cost effectiveness analysis reported
7. Combination epigenetic therapy clinical trial results
8. Results of the PARIS registry Reported at TCT 2011
9. Results of the TRIGGER-PCI trial reported at TCT 2011
10. Results of rapid gene trial reported at TCT 2011
11. Results of the BRIDGE trial reported at TCT 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2020)... ... August 04, 2020 , ... Total ... Autism Spectrum Disorder (ASD) in Wisconsin, is delighted to announce the grand opening ... opening of their newest center, Total Spectrum now proudly serves ten different locations ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... its Suite360:Mental Health and Prevention program district-wide, developed to help students navigate a ... , Florida schools and districts must provide their students with preventative lessons ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... announced enrollment of the first patients with first-line advanced pancreatic cancer in a ... 1/2 1801 trial of 9-ING-41, (NCT03678883, EudraCT#:2018-003739-32). 9-ING-41 is Actuate’s proprietary small ...
(Date:7/31/2020)... ... July 31, 2020 , ... Today Hinge Health, the ... of clinical & technical capabilities to cover the full continuum of care in ... health solution. , Currently, employers interested in truly solving their MSK issues ...
(Date:7/22/2020)... ... 22, 2020 , ... As part of August’s Children’s Eye Health and Safety Month, and as ... Health at Prevent Blindness (NCCVEH) has released an updated version of the report titled ... The goal of the report is , to provide updated ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... July 31, 2020 , ... Member Care Solutions announced ... largest urgent care clinic operators the licensing of their cloud based membership management software ... Care Solutions client family. Our software is the perfect match for many reasons, but ...
(Date:7/22/2020)... ... July 22, 2020 , ... TrialScope, the global leader ... addition of Moderna to its growing customer roster. , TrialScope customers include 16 ... disclosure management, patient engagement and study recruitment. Collectively, TrialScope customers are responsible for ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... extensive awareness campaign to let those who are experiencing abuse know that services ... services they need through the Miami-Dade County’s Coordinated Victim’s Assistance Center (CVAC) helpline. ...
Breaking Medicine Technology: